Morning Briefing
Summaries of health policy coverage from major news organizations
Researchers Begin Clinical Trial Of First Visceral Leishmaniasis Vaccine
"Researchers say they've developed the first vaccine for visceral leishmaniasis (VL) -- a disease that affects 500,000 people each year and has been called the 'parasitic version of HIV,'" although the diseases are unrelated, U.S. News reports. "The vaccine took researchers more than two decades to develop and entered Phase I trials in recent weeks, according to Steve Reed, founder of the Infectious Disease Research Institute (IDRI), the vaccine's developer," the news service writes (Koebler, 2/22).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
